Evidence map›Paper›PMID 40739790›Full record

ArticleDisease models & mechanisms2025

Evidence of neuronal DNA damage in the brains of patients with Rett syndrome.

Abril Morales, Elena Korsakova, Niloufar Mansooralavi, Peter Soliman, Sarvin Jahanbani, Michelle L Olsen, Aparna Badhuri, William E Lowry

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abril MoralesMolecular Biology Institute, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
Elena KorsakovaMolecular Biology Institute, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
Niloufar MansooralaviMolecular Biology Institute, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
Peter SolimanMolecular Biology Institute, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
Sarvin JahanbaniSchool of Neuroscience, Virginia Tech University, Blacksburg, VA 24061, USA.ORCID 0009-0000-0996-471X
Michelle L OlsenSchool of Neuroscience, Virginia Tech University, Blacksburg, VA 24061, USA.ORCID 0000-0003-1394-664X
Aparna BadhuriBroad Center for Regenerative Medicine, UCLA, Los Angeles, CA 90095, USA.
William E LowryMolecular Biology Institute, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.ORCID 0000-0003-2932-2276

Funding

Training Grant in Neurobehavioral GeneticsT32NS048004 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E, OPHOFF, ROEL A · 2004 to 2025
$5.8M
California Institute of Regenerative MedicineInternational Rett Syndrome FoundationNINDS NIH HHS T32 NS048004University of California, Los Angeles
6 · The paper itself

Abstract

Rett syndrome is characterized by the postnatal loss of neurophysiological function and regression of childhood development. Because the syndrome is X linked, and males with MECP2 mutations generally do not survive birth, the study of this syndrome has been complicated by the fact that, in the female brain, a portion of neurons express wild-type MECP2, and another portion of neurons express a non-functional allele of MECP2. Here, we present an approach that enables transcriptional profiling of individual neurons and direct comparison of neurons that express functional MECP2 with those that have diminished MECP2 function. With this novel profiling approach, we found that mutant neurons from the brains of patients with Rett syndrome show patterns of defects in expression of synaptic and metabolic genes. A similar analysis of rat brain lacking MECP2 expression yielded similar patterns, suggesting that rat is a suitable in vivo model of Rett syndrome. These analyses also identified DNA damage and senescence transcriptional signatures specifically in MECP2-null neurons, suggesting a possible trigger of dysfunction in Rett syndrome. Together, these data highlight potentially defective molecular, physiological and metabolic pathways in brain neurons of patients with Rett syndrome.

Indexed as

BrainDNA DamageNeuronsRett SyndromeAgingAnimalsFemaleGene Expression ProfilingGene Expression RegulationHumansMaleMethyl-CpG-Binding Protein 2MiceRatsMECP2 protein, humanMethyl-CpG-Binding Protein 2DNA damageMECP2Rett syndromeSingle-nucleus RNA sequencing

Identifiers

PMID40739790
PMCPMC12452059

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.